← FDA DRUG APPROVALS

FDA ANDA · ANDA200044

PIOGLITAZONE HYDROCHLORIDE

Sponsor: ACCORD HLTHCARE

APPLICATION
ANDA200044
TYPE
ANDA
ORIGINAL APPROVAL
2013-02-13
LATEST ACTION
2020-09-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PIOGLITAZONE HYDROCHLORIDEPrescription
PIOGLITAZONE HYDROCHLORIDE EQ 30MG BASE · TABLET · ORAL
PIOGLITAZONE HYDROCHLORIDEPrescription
PIOGLITAZONE HYDROCHLORIDE EQ 45MG BASE · TABLET · ORAL
PIOGLITAZONE HYDROCHLORIDEPrescription
PIOGLITAZONE HYDROCHLORIDE EQ 15MG BASE · TABLET · ORAL

Approval history

2020-09-08Labeling · Supplement 6 · standardAP
2020-09-08Labeling · Supplement 3 · standardAP
2015-07-21Labeling · Supplement 1 · standardAP
2013-02-13UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →